In the wake of the FTC’s July 9 vote to release an interim staff report on PBMs, several media outlets are reporting that the Commission is poised to sue large PBMs. The timing and nature of the litigation is unspecified,...more
On April 7, the Centers for Medicare & Medicaid Services (CMS) released its highly anticipated final National Coverage Determination (NCD) for Aduhelm and other similar therapies in the pipeline for Alzheimer’s disease. The...more
The Big Picture -
On November 19, the House of Representatives passed the Build Back Better Act (BBB) (H.R. 5376) by a vote of 220–213. The BBB contains a number of health and social policy priorities that are widely viewed...more
12/8/2021
/ American Rescue Plan Act of 2021 ,
Biden Administration ,
Critical Infrastructure Sectors ,
Federal Budget ,
Federal Funding ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Home and Community Based Services (HCBS) ,
Low-Income Issues ,
Medicaid ,
Medicare ,
Pending Legislation ,
Popular ,
Prescription Drugs ,
Regulatory Agenda ,
Tax Credits
The Five Megatrends Shaping Pharma’s Next Decade: Sustaining Success in a New Market Landscape -
Disruptive trends in the healthcare system will force companies to change their strategies. With new care models...more
Avoiding the Regulatory Land Mines of Commercial ACOs -
While providers are showing great interest in creating ACOs to participate in the Medicare Shared Savings Program (MSSP), they are showing even greater enthusiasm...more
7/23/2014
/ ACOs ,
EHR ,
Halifax Hospital ,
Health Insurance ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Medicare ,
Medicare Shared Savings Program ,
Regulatory Standards ,
Reporting Requirements ,
Social Networks ,
Stark Law
Ten Years In: Charting the Progress of Health Information Exchange in the U.S. -
HITECH: Federal Dollars Spur Adoption and Use:
The modern era of HIE-related public policy began in May 2004 with the appointment...more
The Debate over Specialty Pharmaceuticals: Is the Promise Worth the Price? -
..What’s the Issue?
- Specialty pharmaceuticals are a rapidly growing share of total drug expenditures by public and private health...more
10 Megatrends Shaping Healthcare’s Next 10 Years -
The American healthcare system is undergoing massive change. From transformational policies to disruptive technologies to groundbreaking medical advances, powerful...more
As the Healthcare Landscape Shifts, Four Issues Are Critical to Build Effective Market Access Strategies -
In this time of high growth and fast change for the healthcare industry, pharmaceutical, biotechnology and...more
8/20/2013
/ Affordable Care Act ,
Biotechnology ,
Compliance ,
False Claims Act (FCA) ,
Fraud ,
Health Insurance Exchanges ,
Healthcare ,
Insurance Industry ,
Manufacturers ,
Medical Devices ,
Penalties ,
Pharmaceutical Industry ,
Premiums ,
Prescription Drugs ,
Reimbursements
How Does the DOMA Defeat Impact Healthcare Reform and Health Insurance Access? -
NOTE: The Supreme Court's 5-4 decision to invalidate the Defense of Marriage Act (DOMA) will affect more than 1,000 federal statutes—and...more
7/16/2013
/ Affordable Care Act ,
Delays ,
Department of Health and Human Services (HHS) ,
DOMA ,
Employee Benefits ,
Employer Mandates ,
Health Insurance ,
Health Insurance Exchanges ,
Healthcare ,
Healthcare Reform ,
Medicaid ,
Pay or Play ,
Pharmacies ,
Same-Sex Marriage ,
SCOTUS ,
Shared Responsibility Rule ,
U.S. Treasury